After transient silencing of COL6A3 using gene-specific siRNAs, bladder cancer cell lines expressed less TGF-β and exhibited less SMAD2/3 activity, indicated by their hypophosphorylation [40]. This evidence concerns the gene COL6A3 and urinary bladder cancer.